1. MSCs-EVs harboring OA immune memory reprogram macrophage phenotype via modulation of the mt-ND3/NADH-CoQ axis for OA treatment
- Author
-
Jingdi Zhan, Jing Zou, Qiming Pang, Zhuolin Chen, Junyan Liu, Senrui Liu, Chengcheng Du, Jiacheng Liu, Weikang Zhao, Lili Dong, and Wei Huang
- Subjects
MSCs-derived extracellular vesicles ,Engineered ,Macrophages ,Mitochondria metabolism ,mt-ND3 ,Osteoarthritis ,Biotechnology ,TP248.13-248.65 ,Medical technology ,R855-855.5 - Abstract
Abstract Background Osteoarthritis (OA) is a prevalent degenerative joint disease and current therapies are insufficient to halt its progression. Mesenchymal stem cells-derived extracellular vesicles (MSCs-EVs) offer promising therapeutic potential for OA treatment, and their efficacy can be enhanced through strategic engineering approaches. Methods Inspired by the immune memory of the adaptive immune system, we developed an engineered strategy to impart OA-specific immune memory to MSCs-EVs. Using Luminex technology, inflammatory factors (IFN-γ, IL-6, and TNF-α), which mimic the OA inflammatory microenvironment, were identified and used to prime MSCs, generating immune memory-bearing MSCs-EVs (iEVs). Proteomic analysis and complementary experiments were conducted to evaluate iEVs’ effects on macrophage phenotypic reprogramming. Results iEVs, particularly IL-6-EV, exhibited potent immunoregulatory functions along with the ability to modulate mitochondrial metabolism. Both in vitro and in vivo, IL-6-EV significantly reprogrammed macrophages towards the M2 subtype, effectively suppressing articular inflammation and OA progression. Mechanistic studies revealed that IL-6-EV facilitated M2 polarization by regulating mitochondrial oxidative phosphorylation via the mt-ND3/NADH-CoQ axis. Conclusion This study introduces a strategy to enhance MSCs-EVs’ therapeutic efficacy in OA. Multi-omics analysis and biological validation demonstrate its potential, providing new insights for MSCs-EVs’ future application in OA and other clinical conditions. Graphical Abstract more...
- Published
- 2025
- Full Text
- View/download PDF